350 related articles for article (PubMed ID: 27329772)
1. Relative impact of amyloid-β, lacunes, and downstream imaging markers on cognitive trajectories.
Kim HJ; Yang JJ; Kwon H; Kim C; Lee JM; Chun P; Kim YJ; Jung NY; Chin J; Kim S; Woo SY; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Weiner MW; Na DL; Seo SW
Brain; 2016 Sep; 139(Pt 9):2516-27. PubMed ID: 27329772
[TBL] [Abstract][Full Text] [Related]
2. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal cortical thinning and cognitive decline in patients with early- versus late-stage subcortical vascular mild cognitive impairment.
Lee J; Seo SW; Yang JJ; Jang YK; Lee JS; Kim YJ; Chin J; Lee JM; Kim ST; Lee KH; Lee JH; Kim JS; Kim S; Yoo H; Lee AY; Na DL; Kim HJ
Eur J Neurol; 2018 Feb; 25(2):326-333. PubMed ID: 29082576
[TBL] [Abstract][Full Text] [Related]
4. Total MRI Small Vessel Disease Burden Correlates with Cognitive Performance, Cortical Atrophy, and Network Measures in a Memory Clinic Population.
Banerjee G; Jang H; Kim HJ; Kim ST; Kim JS; Lee JH; Im K; Kwon H; Lee JM; Na DL; Seo SW; Werring DJ
J Alzheimers Dis; 2018; 63(4):1485-1497. PubMed ID: 29843234
[TBL] [Abstract][Full Text] [Related]
5. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
[TBL] [Abstract][Full Text] [Related]
6. Clinical effect of white matter network disruption related to amyloid and small vessel disease.
Kim HJ; Im K; Kwon H; Lee JM; Kim C; Kim YJ; Jung NY; Cho H; Ye BS; Noh Y; Kim GH; Ko ED; Kim JS; Choe YS; Lee KH; Kim ST; Lee JH; Ewers M; Weiner MW; Na DL; Seo SW
Neurology; 2015 Jul; 85(1):63-70. PubMed ID: 26062629
[TBL] [Abstract][Full Text] [Related]
7. Amyloid β Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia.
Zhao Y; Tudorascu DL; Lopez OL; Cohen AD; Mathis CA; Aizenstein HJ; Price JC; Kuller LH; Kamboh MI; DeKosky ST; Klunk WE; Snitz BE
JAMA Neurol; 2018 Jan; 75(1):88-96. PubMed ID: 29114732
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of longitudinal amyloid and vascular changes on lobar microbleeds.
Kim YJ; Kim HJ; Park JH; Kim S; Woo SY; Kwak KC; Lee JM; Jung NY; Kim JS; Choe YS; Lee KH; Moon SH; Lee JH; Kim YJ; Werring DJ; Na DL; Seo SW
Neurology; 2016 Oct; 87(15):1575-1582. PubMed ID: 27629091
[TBL] [Abstract][Full Text] [Related]
9. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
Chételat G; Villemagne VL; Pike KE; Ellis KA; Bourgeat P; Jones G; O'Keefe GJ; Salvado O; Szoeke C; Martins RN; Ames D; Masters CL; Rowe CC;
Brain; 2011 Mar; 134(Pt 3):798-807. PubMed ID: 21310725
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment.
Park JH; Seo SW; Kim C; Kim GH; Noh HJ; Kim ST; Kwak KC; Yoon U; Lee JM; Lee JW; Shin JS; Kim CH; Noh Y; Cho H; Kim HJ; Yoon CW; Oh SJ; Kim JS; Choe YS; Lee KH; Lee JH; Ewers M; Weiner MW; Werring DJ; Na DL
Ann Neurol; 2013 May; 73(5):584-93. PubMed ID: 23495089
[TBL] [Abstract][Full Text] [Related]
11. Hippocampal and cortical atrophy in amyloid-negative mild cognitive impairments: comparison with amyloid-positive mild cognitive impairment.
Ye BS; Seo SW; Kim CH; Jeon S; Kim GH; Noh Y; Cho H; Yoon CW; Kim HJ; Jang EY; Lee J; Kim JH; Chin J; Lee JM; Kim JH; Seong JK; Kim CH; Choe YS; Lee KH; Na DL
Neurobiol Aging; 2014 Feb; 35(2):291-300. PubMed ID: 24080178
[TBL] [Abstract][Full Text] [Related]
12. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
Oh H; Madison C; Baker S; Rabinovici G; Jagust W
Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
[TBL] [Abstract][Full Text] [Related]
13. Effects of cerebrovascular disease and amyloid beta burden on cognition in subjects with subcortical vascular cognitive impairment.
Park JH; Seo SW; Kim C; Kim SH; Kim GH; Kim ST; Jeon S; Lee JM; Oh SJ; Kim JS; Choe YS; Lee KH; Shin JS; Kim CH; Noh Y; Cho H; Yoon CW; Kim HJ; Ye BS; Ewers M; Weiner MW; Lee JH; Werring DJ; Na DL
Neurobiol Aging; 2014 Jan; 35(1):254-60. PubMed ID: 23932881
[TBL] [Abstract][Full Text] [Related]
14. Effects of amyloid and small vessel disease on white matter network disruption.
Kim HJ; Im K; Kwon H; Lee JM; Ye BS; Kim YJ; Cho H; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Na DL; Seo SW
J Alzheimers Dis; 2015; 44(3):963-75. PubMed ID: 25374100
[TBL] [Abstract][Full Text] [Related]
15. Vascular Effects on Depressive Symptoms in Cognitive Impairment.
Kim Y; Jang H; Kim SJ; Cho SH; Kim SE; Kim ST; Kim HJ; Moon SH; Ewers M; Im K; Kwon H; Na DL; Seo SW
J Alzheimers Dis; 2018; 65(2):597-605. PubMed ID: 30056427
[TBL] [Abstract][Full Text] [Related]
16. MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden.
Banerjee G; Kim HJ; Fox Z; Jäger HR; Wilson D; Charidimou A; Na HK; Na DL; Seo SW; Werring DJ
Brain; 2017 Apr; 140(4):1107-1116. PubMed ID: 28335021
[TBL] [Abstract][Full Text] [Related]
17. Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly.
Vemuri P; Lesnick TG; Przybelski SA; Knopman DS; Preboske GM; Kantarci K; Raman MR; Machulda MM; Mielke MM; Lowe VJ; Senjem ML; Gunter JL; Rocca WA; Roberts RO; Petersen RC; Jack CR
Brain; 2015 Mar; 138(Pt 3):761-71. PubMed ID: 25595145
[TBL] [Abstract][Full Text] [Related]
18. Fluorodeoxyglucose metabolism associated with tau-amyloid interaction predicts memory decline.
Hanseeuw BJ; Betensky RA; Schultz AP; Papp KV; Mormino EC; Sepulcre J; Bark JS; Cosio DM; LaPoint M; Chhatwal JP; Rentz DM; Sperling RA; Johnson KA
Ann Neurol; 2017 Apr; 81(4):583-596. PubMed ID: 28253546
[TBL] [Abstract][Full Text] [Related]
19. Cognitive decline and amyloid accumulation in patients with mild cognitive impairment.
Koivunen J; Karrasch M; Scheinin NM; Aalto S; Vahlberg T; Någren K; Helin S; Viitanen M; Rinne JO
Dement Geriatr Cogn Disord; 2012; 34(1):31-7. PubMed ID: 22868352
[TBL] [Abstract][Full Text] [Related]
20. Effects of APOE ε4 on brain amyloid, lacunar infarcts, and white matter lesions: a study among patients with subcortical vascular cognitive impairment.
Kim HJ; Ye BS; Yoon CW; Cho H; Noh Y; Kim GH; Choi YS; Kim JH; Jeon S; Lee JM; Kim JS; Choe YS; Lee KH; Kim ST; Kim C; Kang DR; Ki CS; Lee JH; Werring DJ; Weiner MW; Na DL; Seo SW
Neurobiol Aging; 2013 Nov; 34(11):2482-7. PubMed ID: 23769398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
